Literature DB >> 1906447

Effect of a bulk-forming cathartic on diarrhea in tube-fed patients.

D J Heather1, L Howell, M Montana, M Howell, R Hill.   

Abstract

Diarrhea is a significant complication for the patient being tube-fed. The purpose of this study was to observe whether giving a bulk-forming cathartic to patients receiving enteral nutrition via nasogastric or nasoduodenal tube would result in firmer stools for these patients. Forty-nine patients in a large medical center were randomly assigned to either a control or an experimental group. During the 6-day study period 1 teaspoon (5 ml) of psyllium preparation was administered through the feeding tube three times a day. Data were analyzed by using the Mann-Whitney U test for nonparametric data. The hypothesis that giving a bulk-forming cathartic would lead to firmer stools was supported at an alpha level of less than 0.01. The results of this study suggest that use of a bulk-forming cathartic in tube-fed patients will significantly reduce the diarrhea associated with this type of feeding.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1906447

Source DB:  PubMed          Journal:  Heart Lung        ISSN: 0147-9563            Impact factor:   2.210


  4 in total

Review 1.  Fiber and prebiotic supplementation in enteral nutrition: A systematic review and meta-analysis.

Authors:  Mazuin Kamarul Zaman; Kin-Fah Chin; Vineya Rai; Hazreen Abdul Majid
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

Review 2.  Antidiarrheal Drug Therapy.

Authors:  Lawrence R Schiller
Journal:  Curr Gastroenterol Rep       Date:  2017-05

3.  ACG Clinical Guideline: Nutrition Therapy in the Adult Hospitalized Patient.

Authors:  Stephen A McClave; John K DiBaise; Gerard E Mullin; Robert G Martindale
Journal:  Am J Gastroenterol       Date:  2016-03-08       Impact factor: 10.864

4.  Dietary fiber in irritable bowel syndrome (Review).

Authors:  Magdy El-Salhy; Synne Otterasen Ystad; Tarek Mazzawi; Doris Gundersen
Journal:  Int J Mol Med       Date:  2017-07-19       Impact factor: 4.101

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.